Clinical Trial Update: Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib hydrochloride given before surgery in patients with renal cell carcinoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-12